ZipBio raised $4M in a seed funding round led by NFX to develop a platform for compressing proteins using generative AI.
PRIVATESep 09, 2024
Amount Raised
$4 Million
Round Type
Seed
SeattleBiotechnology
Investors
More VcNfx
Description
Seattle-based biotech startup ZipBio announced its official launch and revealed $4 million in a seed funding round. The funding will help ZipBio develop its platform aimed at optimizing delivery and therapeutic effectiveness of proteins.
Who to call at ZipBio, and when
A new round usually means ZipBio is about to hire and buy. The teams that reach out first get the meeting.
An alert the day ZipBio raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at ZipBio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ZipBio. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
ZipBio
Location
Seattle, Washington, United States
About
ZipBio is a Seattle-based biotech startup focused on compressing complex biological structures into smaller, more efficient proteins. Utilizing generative AI, the company aims to develop new therapeutics that address critical unmet needs in medicine. Their platform creates de novo genes and proteins, optimizing therapeutic delivery and effectiveness.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ZipBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SeattleBiotechnology